Provided By GlobeNewswire
Last update: Mar 25, 2025
Update on IND-enabling data for MP0712, a Radio-DARPin targeting DLL3 and labeled with 212Pb, co-developed with Orano Med; entering FIH studies in 2025 for the treatment of small cell lung cancer
Read more at globenewswire.comNASDAQ:MOLN (11/14/2025, 8:06:09 PM)
4.22
-0.06 (-1.4%)
Find more stocks in the Stock Screener


